A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cassava Sciences Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 22,306 shares of SAVA stock, worth $590,662. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,306
Previous 21,151 5.46%
Holding current value
$590,662
Previous $261,000 151.34%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$9.57 - $35.08 $11,053 - $40,517
1,155 Added 5.46%
22,306 $656,000
Q2 2024

Aug 14, 2024

BUY
$12.35 - $26.11 $261,214 - $552,252
21,151 New
21,151 $261,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $1.06B
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.